Catalyst Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.8K | Sell |
|
|||||
|
2025
Q2 | $34.1K | Sell |
|
|||||
|
2025
Q1 | $53.9K | Buy |
|
|||||
|
2024
Q4 | $59.8K | Hold |
|
|||||
|
2024
Q3 | $88.3K | Sell |
|
|||||
|
2024
Q2 | $109K | Buy |
|
|||||
|
2024
Q1 | $97.2K | Buy |
|
|||||
|
2023
Q4 | $87.8K | Buy |
|
|||||
|
2023
Q3 | $65.8K | Buy |
|
|||||
|
2023
Q2 | $42.4K | Buy |
|
|||||
|
2023
Q1 | $47.7K | Sell |
|
|||||
|
2022
Q4 | $60.6K | Sell |
|
|||||
|
2022
Q3 | $59K | Hold |
|
|||||
|
2022
Q2 | $50K | Sell |
|
|||||
|
2022
Q1 | $99K | Buy |
|
|||||
|
2021
Q4 | $37K | Sell |
|
|||||
|
2021
Q3 | $54K | Buy |
|
|||||
|
2021
Q2 | $36K | Buy |
|
|||||
|
2021
Q1 | $29K | Sell |
|
|||||
|
2020
Q4 | $36K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $41K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3.71M | Hold |
|
|||||
|
2015
Q4 | $5.59M | Buy |
|
|||||
|
2015
Q3 | $2.7M | Sell |
|
|||||
|
2015
Q2 | $7.65M | Buy |
|